Abstract Background Glypican 3 (GPC3) is a heparin sulphate proteoglycan whose
expression is associated with several malignancies. However, its expression in non-small …

Abstract Glypican-3 (GPC3), a membrane-bound heparan sulfate proteoglycan, has long
been found to be dysregulated in human lung adenocarcinomas (LUADs). Nevertheless, the …

Abstract Background Glypican-3 (GPC3) is a cell surface-bound proteoglycan which has
been identified as a potential biomarker candidate in hepatocellular carcinoma, lung …

The purpose of this study was to investigate GPC3 gene expression in lung squamous cell
carcinoma tissue and its correlation with clinical and tumor characteristics. Using RT–PCR …

Abstract Glypican-5 (GPC5) is a member of the heparin sulfate proteoglycans. Previous
studies of GPC5 in lung tumorigenesis showed conflicting results. In this study, we confirmed …

In this study, we examined the expression of glypican-3 (GPC3) in the 2 most common
histological types of lung cancer, squamous cell carcinoma and adenocarcinoma, and …

As a cell surface proteoglycan anchored by glycosyl-phosphatidylinositol, Glypican-3
(GPC3) is reported to be highly expressed in hepatocellular carcinoma (HCC) and to …

Although the correlation between glypican-5 (GPC5) and lung cancer is well known, the
effect of GPC5 expression on non-small cell lung cancer (NSCLC) survival remains to be …

Glypican-1 (GPC-1) and other glypicans are a family of heparan sulfate proteoglycans.
These proteins are highly expressed on the cell membrane and in the extracellular matrix …

Recently, a five-center collaborative study1 reported that genetic variations of glypican-5
(GPC5) may significantly contribute to an increased risk of lung cancer in never smokers …